Hochschulschrift
Impairment in proopiomelanocortin – mu opioid receptor antinociceptive pathway contributes to painful diabetic neuropathy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Heidelberg, Universität Heidelberg, Dissertation, 2017
- Schlagwort
-
Diabetes
Pain
Diabetic neuropathies
Opioid peptides
Proopiomelanocortin
diabetes
pain
POMC
- Ereignis
-
Veröffentlichung
- (wo)
-
Heidelberg
- (wer)
-
Universitätsbibliothek Heidelberg
- (wann)
-
2018
- Urheber
- Beteiligte Personen und Organisationen
-
Martin-Villalba, Ana
- DOI
-
10.11588/heidok.00023697
- URN
-
urn:nbn:de:bsz:16-heidok-236976
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Deshpande, Divija
- Martin-Villalba, Ana
- Universitätsbibliothek Heidelberg
Entstanden
- 2018
Ähnliche Objekte (12)
Impairment in proopiomelanocortin - mu opioid receptor antinociceptive pathway contibutes to painful diabetic neuropathy
Painful Peripheral Neuropathy and Cancer
HIV-associated painful neuropathy: where are we?
Diabetic Painful Neuropathy and Restless Legs Syndrome in Diabetes
Healthcare costs and medical utilization patterns associated with painful and severe painful diabetic peripheral neuropathy
Pharmacological Effects of Paeonia lactiflora Focusing on Painful Diabetic Neuropathy
Phytochemical and Antinociceptive Investigations of Anemone coronaria Active Part Ameliorating Diabetic Neuropathy Pain
Spinal Cord Stimulation for Painful Diabetic Peripheral Neuropathy: A Systematic Review
Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review
Botulinum toxin type A for painful diabetic neuropathy: an open-label study
PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects
TRPV1 channel inhibition contributes to the antinociceptive effects of Croton macrostachyus extract in mice
Impairment in proopiomelanocortin - mu opioid receptor antinociceptive pathway contibutes to painful diabetic neuropathy
Painful Peripheral Neuropathy and Cancer
HIV-associated painful neuropathy: where are we?
Diabetic Painful Neuropathy and Restless Legs Syndrome in Diabetes
Healthcare costs and medical utilization patterns associated with painful and severe painful diabetic peripheral neuropathy
Pharmacological Effects of Paeonia lactiflora Focusing on Painful Diabetic Neuropathy
Phytochemical and Antinociceptive Investigations of Anemone coronaria Active Part Ameliorating Diabetic Neuropathy Pain
Spinal Cord Stimulation for Painful Diabetic Peripheral Neuropathy: A Systematic Review
Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review
Botulinum toxin type A for painful diabetic neuropathy: an open-label study
PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects
TRPV1 channel inhibition contributes to the antinociceptive effects of Croton macrostachyus extract in mice
Impairment in proopiomelanocortin - mu opioid receptor antinociceptive pathway contibutes to painful diabetic neuropathy
Painful Peripheral Neuropathy and Cancer
HIV-associated painful neuropathy: where are we?
Diabetic Painful Neuropathy and Restless Legs Syndrome in Diabetes
Healthcare costs and medical utilization patterns associated with painful and severe painful diabetic peripheral neuropathy
Pharmacological Effects of Paeonia lactiflora Focusing on Painful Diabetic Neuropathy
Phytochemical and Antinociceptive Investigations of Anemone coronaria Active Part Ameliorating Diabetic Neuropathy Pain
Spinal Cord Stimulation for Painful Diabetic Peripheral Neuropathy: A Systematic Review
Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review
Botulinum toxin type A for painful diabetic neuropathy: an open-label study
PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects